Georgia hospitals launch trials of a promising pancreatic cancer drug
TL;DR
Researchers at Emory University’s Winship Cancer Institute and Piedmont Atlanta Hospital are testing daraxonrasib, an experimental pancreatic cancer drug, after FDA early-access approval; early results show tumor shrinkage with fewer side effects than standard chemotherapy, offering hope for patients facing one of the deadliest cancers.
Topics:healthhealth-news#clinical-trials#emory-university#health-news#kras#pancreatic-cancer#piedmont-atlanta-hospital
- Georgia hospitals test ‘game-changer’ pancreatic cancer drugs Atlanta Journal-Constitution
- Breakthrough pancreatic cancer drug nearly doubles survival in trial USA Today
- A New Targeted Option on the Horizon for Pancreatic Cancer – CancerWorld Oncodaily
- ASCO 2026 Ushers In a New Era for Pancreatic Cancer, Expands Targeted Therapy Options Across the GI Spectrum OncLive
- Local advocates tout new pancreatic cancer treatment as a breakthrough KOB.com
Want the full story? Read the original reporting
Read on Atlanta Journal-Constitution